Differential proteomic analysis of human erythroblasts undergoing apoptosis induced by Epo-withdrawal

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Pellegrin, Stéphanie ^a   Heesom, Kate J ^a   Satchwell, Timothy J ^a   Hawley, Bethan R ^a   Daniels, Geoff ^b   van den Akker, Emile ^c   Toye, Ashley M ^a,b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

^c SANQUIN RESEARCH   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CD34 ANTIGEN; CELL SURFACE PROTEIN; CYTOCHROME C; ERYTHROPOIETIN; HEAT SHOCK PROTEIN 90; LIPOCORTIN 5; PROTEIN 14 3 3; PROTEIN 14 3 3 BETA; PROTEIN 14 3 3 EPSILON; PROTEIN 14 3 3 GAMMA; PROTEIN BAX; PROTEIN HSP90 ALPHA; PROTEIN HSP90 BETA; PROTEIN RPSA; PROTEIN SET; PROTEOME; STEM CELL FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BLOOD CELL; CELL GROWTH; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVATION; ENZYME RELEASE; ERYTHROBLAST; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MITOCHONDRIAL MEMBRANE POTENTIAL; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; PROTEIN TRANSPORT; PROTEOMICS; SIGNAL TRANSDUCTION; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

APOPTOSIS; CASPASES; CELL DIFFERENTIATION; CELLS, CULTURED; ERYTHROBLASTS; ERYTHROID PRECURSOR CELLS; ERYTHROPOIETIN; HUMANS; PHOSPHORYLATION; PRIMARY CELL CULTURE; PROTEINS; PROTEOLYSIS; PROTEOME; PROTEOMICS; TIME FACTORS;

EID: 84862504651     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038356     Document Type: Article

References (61)

1. Muta K, Krantz SB, Bondurant MC, Wickrema A, (1994) Distinct roles of erythropoietin, insulin-like growth factor I, and stem cell factor in the development of erythroid progenitor cells. J Clin Invest 94: 34-43.
2. Wessely O, Deiner EM, Beug H, von Lindern M, (1997) The glucocorticoid receptor is a key regulator of the decision between self-renewal and differentiation in erythroid progenitors. EMBO J 16: 267-280.
3. Jelkmann WE, (2010) Regulation of erythropoietin production. J Physiol.
4. Wu H, Liu X, Jaenisch R, Lodish HF, (1995) Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83: 59-67.
5. Koury MJ, Bondurant MC, (1990) Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 248: 378-381.
6. D'Andrea AD, Lodish HF, Wong GG, (1989) Expression cloning of the murine erythropoietin receptor. Cell 57: 277-285.
7. Witthuhn BA, Quelle FW, Silvennoinen O, Yi T, Tang B, et al. (1993) JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74: 227-236.
8. Damen JE, Cutler RL, Jiao H, Yi T, Krystal G, (1995) Phosphorylation of tyrosine 503 in the erythropoietin receptor (EpR) is essential for binding the P85 subunit of phosphatidylinositol (PI) 3-kinase and for EpR-associated PI 3-kinase activity. J Biol Chem 270: 23402-23408.
9. Klingmuller U, Lorenz U, Cantley LC, Neel BG, Lodish HF, (1995) Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 80: 729-738.
10. Quelle FW, Wang D, Nosaka T, Thierfelder WE, Stravopodis D, et al. (1996) Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. Mol Cell Biol 16: 1622-1631.
11. Richmond TD, Chohan M, Barber DL, (2005) Turning cells red: signal transduction mediated by erythropoietin. Trends Cell Biol 15: 146-155.
12. Hellstrom-Lindberg E, Kanter-Lewensohn L, Ost A, (1997) Morphological changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with granulocyte-CSF and erythropoietin. Leuk Res 21: 415-425.
13. Wojchowski DM, Sathyanarayana P, Dev A, (2010) Erythropoietin receptor response circuits. Curr Opin Hematol 17: 169-176.
14. Abutin RM, Chen J, Lung TK, Lloyd JA, Sawyer ST, et al. (2009) Erythropoietin-induced phosphorylation/degradation of BIM contributes to survival of erythroid cells. Exp Hematol 37: 151-158.
15. Deng H, Zhang J, Yoon T, Song D, Li D, et al. (2011) Phosphorylation of Bcl-associated death protein (Bad) by erythropoietin-activated c-Jun N-terminal protein kinase 1 contributes to survival of erythropoietin-dependent cells. Int J Biochem Cell Biol 43: 409-415.
16. Sathyanarayana P, Dev A, Fang J, Houde E, Bogacheva O, et al. (2008) EPO receptor circuits for primary erythroblast survival. Blood 111: 5390-5399.
17. Somervaille TC, Linch DC, Khwaja A, (2001) Growth factor withdrawal from primary human erythroid progenitors induces apoptosis through a pathway involving glycogen synthase kinase-3 and Bax. Blood 98: 1374-1381.
18. Ribeil JA, Zermati Y, Vandekerckhove J, Cathelin S, Kersual J, et al. (2007) Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1. Nature 445: 102-105.
19. Lui JC, Kong SK, (2007) Heat shock protein 70 inhibits the nuclear import of apoptosis-inducing factor to avoid DNA fragmentation in TF-1 cells during erythropoiesis. FEBS Lett 581: 109-117.
20. Ohtsuka R, Abe Y, Fujii T, Yamamoto M, Nishimura J, et al. (2007) Mortalin is a novel mediator of erythropoietin signaling. Eur J Haematol 79: 114-125.
21. van den Akker E, Satchwell TJ, Pellegrin S, Daniels G, Toye AM, (2010) The majority of the in vitro erythroid expansion potential resides in CD34(-) cells, outweighing the contribution of CD34(+) cells and significantly increasing the erythroblast yield from peripheral blood samples. Haematologica 95: 1594-1598.
22. Satchwell TJ, Bell AJ, Pellegrin S, Kupzig S, Ridgwell K, et al. (2011) Critical band 3 multiprotein complex interactions establish early during human erythropoiesis. Blood 118: 182-191.
23. Shawgo ME, Shelton SN, Robertson JD, (2008) Caspase-mediated Bak activation and cytochrome c release during intrinsic apoptotic cell death in Jurkat cells. J Biol Chem 283: 35532-35538.
24. Chepanoske CL, Richardson BE, von Rechenberg M, Peltier JM, (2005) Average peptide score: a useful parameter for identification of proteins derived from database searches of liquid chromatography/tandem mass spectrometry data. Rapid Commun Mass Spectrom 19: 9-14.
25. De Maria R, Testa U, Luchetti L, Zeuner A, Stassi G, et al. (1999) Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis. Blood 93: 796-803.
26. Gregoli PA, Bondurant MC, (1999) Function of caspases in regulating apoptosis caused by erythropoietin deprivation in erythroid progenitors. J Cell Physiol 178: 133-143.
27. Tait SW, Green DR, (2010) Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 11: 621-632.
28. Li H, Zhu H, Xu CJ, Yuan J, (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491-501.
29. Viswanath V, Wu Y, Boonplueang R, Chen S, Stevenson FF, et al. (2001) Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease. J Neurosci 21: 9519-9528.
30. Cornelis S, Bruynooghe Y, Van Loo G, Saelens X, Vandenabeele P, et al. (2005) Apoptosis of hematopoietic cells induced by growth factor withdrawal is associated with caspase-9 mediated cleavage of Raf-1. Oncogene 24: 1552-1562.
31. Letai A, (2006) Growth factor withdrawal and apoptosis: the middle game. Mol Cell 21: 728-730.
32. Fischer U, Janicke RU, Schulze-Osthoff K, (2003) Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ 10: 76-100.
33. He B, Lu N, Zhou Z, (2009) Cellular and nuclear degradation during apoptosis. Curr Opin Cell Biol 21: 900-912.
34. Chen H, Xia Y, Fang D, Hawke D, Lu Z, (2009) Caspase-10-mediated heat shock protein 90 beta cleavage promotes UVB irradiation-induced cell apoptosis. Mol Cell Biol 29: 3657-3664.
35. Kuzelova K, Grebenova D, Pluskalova M, Kavan D, Halada P, et al. (2009) Isoform-specific cleavage of 14-3-3 proteins in apoptotic JURL-MK1 cells. J Cell Biochem 106: 673-681.
36. Taylor RC, Cullen SP, Martin SJ, (2008) Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 9: 231-241.
37. Marubayashi S, Koppikar P, Taldone T, Abdel-Wahab O, West N, et al. (2010) HSP90 is a therapeutic target in JAK2-dependent myeloproliferative neoplasms in mice and humans. J Clin Invest 120: 3578-3593.
38. Ando K, Miyazaki Y, Sawayama Y, Tominaga S, Matsuo E, et al. (2011) High expression of 67-kDa laminin receptor relates to the proliferation of leukemia cells and increases expression of GM-CSF receptor. Exp Hematol 39: 179-186 e174.
39. Samanta AK, Chakraborty SN, Wang Y, Kantarjian H, Sun X, et al. (2009) Jak2 inhibition deactivates Lyn kinase through the SET-PP2A-SHP1 pathway, causing apoptosis in drug-resistant cells from chronic myelogenous leukemia patients. Oncogene 28: 1669-1681.
40. Whitesell L, Lindquist SL, (2005) HSP90 and the chaperoning of cancer. Nat Rev Cancer 5: 761-772.
41. Shay KP, Wang Z, Xing PX, McKenzie IF, Magnuson NS, (2005) Pim-1 kinase stability is regulated by heat shock proteins and the ubiquitin-proteasome pathway. Mol Cancer Res 3: 170-181.
42. Kurokawa M, Zhao C, Reya T, Kornbluth S, (2008) Inhibition of apoptosome formation by suppression of Hsp90beta phosphorylation in tyrosine kinase-induced leukemias. Mol Cell Biol 28: 5494-5506.
43. Quelo I, Akhouayri O, Prud'homme J, St-Arnaud R, (2004) GSK3 beta-dependent phosphorylation of the alpha NAC coactivator regulates its nuclear translocation and proteasome-mediated degradation. Biochemistry 43: 2906-2914.
44. Jin J, Smith FD, Stark C, Wells CD, Fawcett JP, et al. (2004) Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr Biol 14: 1436-1450.
45. Polzien L, Baljuls A, Rennefahrt UE, Fischer A, Schmitz W, et al. (2009) Identification of novel in vivo phosphorylation sites of the human proapoptotic protein BAD: pore-forming activity of BAD is regulated by phosphorylation. J Biol Chem 284: 28004-28020.
46. Zhao X, Gan L, Pan H, Kan D, Majeski M, et al. (2004) Multiple elements regulate nuclear/cytoplasmic shuttling of FOXO1: characterization of phosphorylation- and 14-3-3-dependent and-independent mechanisms. Biochem J 378: 839-849.
47. Li M, Makkinje A, Damuni Z, (1996) The myeloid leukemia-associated protein SET is a potent inhibitor of protein phosphatase 2A. J Biol Chem 271: 11059-11062.
48. von Lindern M, van Baal S, Wiegant J, Raap A, Hagemeijer A, et al. (1992) Can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3' half to different genes: characterization of the set gene. Mol Cell Biol 12: 3346-3355.
49. Canela N, Rodriguez-Vilarrupla A, Estanyol JM, Diaz C, Pujol MJ, et al. (2003) The SET protein regulates G2/M transition by modulating cyclin B-cyclin-dependent kinase 1 activity. J Biol Chem 278: 1158-1164.
50. Vera J, Jaumot M, Estanyol JM, Brun S, Agell N, et al. (2006) Heterogeneous nuclear ribonucleoprotein A2 is a SET-binding protein and a PP2A inhibitor. Oncogene 25: 260-270.
51. Malygin AA, Babaylova ES, Loktev VB, Karpova GG, (2011) A region in the C-terminal domain of ribosomal protein SA required for binding of SA to the human 40S ribosomal subunit. Biochimie 93: 612-617.
52. McLaughlin SH, Sobott F, Yao ZP, Zhang W, Nielsen PR, et al. (2006) The co-chaperone p23 arrests the Hsp90 ATPase cycle to trap client proteins. J Mol Biol 356: 746-758.
53. Davies TH, Sanchez ER, (2005) FKBP52. Int J Biochem Cell Biol 37: 42-47.
54. de Thonel A, Vandekerckhove J, Lanneau D, Selvakumar S, Courtois G, et al. (2010) HSP27 controls GATA-1 protein level during erythroid cell differentiation. Blood 116: 85-96.
55. Rudel T, Zenke FT, Chuang TH, Bokoch GM, (1998) p21-activated kinase (PAK) is required for Fas-induced JNK activation in Jurkat cells. J Immunol 160: 7-11.
56. Ayllon V, Martinez AC, Garcia A, Cayla X, Rebollo A, (2000) Protein phosphatase 1alpha is a Ras-activated Bad phosphatase that regulates interleukin-2 deprivation-induced apoptosis. EMBO J 19: 2237-2246.
57. Revil T, Pelletier J, Toutant J, Cloutier A, Chabot B, (2009) Heterogeneous nuclear ribonucleoprotein K represses the production of pro-apoptotic Bcl-xS splice isoform. J Biol Chem 284: 21458-21467.
58. Rhodes MM, Kopsombut P, Bondurant MC, Price JO, Koury MJ, (2005) Bcl-x(L) prevents apoptosis of late-stage erythroblasts but does not mediate the antiapoptotic effect of erythropoietin. Blood 106: 1857-1863.
59. Christian KJ, Lang MA, Raffalli-Mathieu F, (2008) Interaction of heterogeneous nuclear ribonucleoprotein C1/C2 with a novel cis-regulatory element within p53 mRNA as a response to cytostatic drug treatment. Mol Pharmacol 73: 1558-1567.
60. Zhang J, Bahi N, Llovera M, Comella JX, Sanchis D, (2009) Polypyrimidine tract binding proteins (PTB) regulate the expression of apoptotic genes and susceptibility to caspase-dependent apoptosis in differentiating cardiomyocytes. Cell Death Differ 16: 1460-1468.
61. Lees-Miller SP, Anderson CW, (1989) Two human 90-kDa heat shock proteins are phosphorylated in vivo at conserved serines that are phosphorylated in vitro by casein kinase II. J Biol Chem 264: 2431-2437.